Literature DB >> 3057632

Treatment of disseminated intravascular coagulation.

D I Feinstein1.   

Abstract

The treatment of DIC is extremely complex, stemming from the fact that it complicates many different disorders and may have a variety of clinical manifestations. In addition, there continues to be a lack of well-controlled studies regarding various methods of management in relatively homogeneous groups of patients. Therefore treatment continues to be controversial and probably will remain so in the near future. However, it is clear that any careful clinical and laboratory observations in groups of patients with the same underlying disorder are extremely helpful in elucidating the natural history of the process, in determining its effect on the patient, and clarifying whether certain therapeutic interventions may be helpful. Therefore the continued accumulation of careful clinical studies will help in determining the proper management of DIC in patients with the same underlying disorder and in given individual situations.

Entities:  

Mesh:

Year:  1988        PMID: 3057632     DOI: 10.1055/s-2007-1002795

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  A 72-year-old woman with fever and diffuse intravascular coagulation.

Authors:  C F Allaart; G J den Ottolander; E Briët; R Bieger
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

2.  Fatality from disseminated intravascular coagulation complicating total hip arthroplasty: a case report.

Authors:  S M Sporer; J J Callaghan
Journal:  Iowa Orthop J       Date:  1997

Review 3.  Acute promyelocytic leukaemia in the all trans retinoic acid era.

Authors:  T G DeLoughery; S H Goodnight
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

4.  Management of disseminated intravascular coagulation in a patient with hepatic angiosarcoma: A case report.

Authors:  Emily A Rosen; Mounica Vallurupalli; Edwin Choy; Jochen K Lennerz; David J Kuter
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.